Goldman Sachs Emerging Markets Eq Income N Dis EUR

The fund mainly invests in emerging market shares. Many countries in this region are developing strongly. There are interesting trends that the fund managers, thanks to local expertise, can effectively capitalise on. When selecting shares, the emphasis is on the level and sustainability of the dividend that companies distribute.

Yield overview (after costs)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 (YTD) i
8,94 -9,52 18,91 11,83 -7,55 13,34 11,11 1,59 -17,89 8,69 18,61

Back to overview

  • Date 17-09-2024
  • Price € 880,11 i
  • Performance YTD 18,61% i
  • Performance 8,69% i i
  • Interest rate sensitivity Interest rate sensitivity 0,80% i
  • Ongoing charges -- i
  • Transaction costs
    with € 1.000,-
    example
    --
    i
  • Dividend € 25,73 i
  • Morningstar

Source: Morningstar

With FitVermogen you only pay the costs of the investment fund. These costs are already included in the price.
The Fund is classified as a financial product under Article 8 of the EU Sustainable Finance Disclosure Regulation. The Fund promotes environmental or social characteristics but does not have a sustainable investment objective. The Fund integrates ESG factors and risk in the investment process alongside traditional factors. Detailed information on the sustainability related disclosures of the Fund can be found in the Template Pre-contractual disclosure (annex of the prospectus) on https://www.gsam.com/responsible-investing/en-INT/non-professional/funds/documents. The fund invests in companies, established, listed or traded in any emerging or developing country in Latin America (including the Caribbean), Asia (excluding Japan), Eastern Europe, the Middle East and Africa. The dividend yield (dividend as a percentage of the share price) of the portfolio is targeted to be superior to the benchmark. The portfolio is diversified across countries and business sectors. The fund uses active management to target companies that score well according to our fundamental in-vestment process, with stock and sector deviation limits maintained relative to the benchmark. Its stock-level composition will therefore materially deviate from the benchmark. The Fund may also invest directly, up to 20% of its net assets, in mainland China via Stock Connect which is the mutual market access programme through which investors can deal in selected securities. Measured over a period of several years, we aim to beat the performance of the benchmark MSCI Emerging Markets (NR). The benchmark is a broad representation of our investment universe. The fund may also include investments into securities that are not part of the benchmark universe. The fund’s stock selection process is driven by the analysis of fundamental data and includes the consideration of ESG factors. You can sell your participation in this fund on each (working) day on which the value of the units is calculated, which for this fund occurs daily. The fund aims at providing you with an annual dividend.
These financial instruments are impacted by various factors. These include, but are not limited to, the development of the financial market, the economic development of issuers of these financial instruments who are themselves affected by the general world economic situation and the economic and political conditions in each country. The Sub-Fund’s liquidity risk is set to high. Liquidity risks may arise when a specific underlying investment is difficult to sell. Moreover, currency fluctuation may impact highly the Sub-Fund’s performance. Investments in a specific theme are more concentrated than investments in various themes. No guarantee is provided as to the recovery of the initial investment. The fund may invest in China A-shares through Stock Connect, a system facilitating equity investment to the Chinese market. Investments through this system are subject to specific risks, including but not limited to, quota limitations, trading restrictions, recalling of eligible stocks, clearing and settlement risk and regulatory risk. Investors are advised to familiarise themselves with the risks of this system as outlined in the prospectus.

The fund mainly invests in emerging market shares. Many countries in this region are developing strongly. There are interesting trends that the fund managers, thanks to local expertise, can effectively capitalise on. When selecting shares, the emphasis is on the level and sustainability of the dividend that companies distribute.

loading...

Back to overview

  • Date 17-09-2024
  • Price € 880,11 i
  • Performance YTD 18,61% i
  • Performance 8,69% i i
  • Interest rate sensitivity Interest rate sensitivity 0,80% i
  • Ongoing charges -- i
  • Transaction costs
    with € 1.000,-
    example
    --
    i
  • Dividend € 25,73 i
  • Morningstar

Source: Morningstar

With FitVermogen you only pay the costs of the investment fund. These costs are already included in the price.
Growth of EUR 1000 (EUR) 16-09-2024
Return per year 16-09-2024
  2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 (YTD) i
Return (%) 8,94 -9,52 18,91 11,83 -7,55 13,34 11,11 1,59 -17,89 8,69 18,61

Source: Morningstar

Past performance is not indicative of future results and should in no event be deemed as such. Returns are presented after all transactions costs.

Back to overview

Disclaimer  |  Security  |  Privacy statement  |  Legal information  |  Contact